Other Events ·
Stockholders approve amendment to increase authorized common stock from 207,046 to 896,546 shares
ICUSeaStar Medical Holding Corp
On June 17, 2026, stockholders approved an amendment and restatement of the 2022 Omnibus Incentive Plan, increasing the number of authorized shares of common stock from 207,046 to 896,546. The company also elected John Neuman as a Class I director and ratified WithumSmith+Brown, PC as its independent registered public accounting firm for the fiscal year ending December 31, 2026. SeaStar Medical Holding Corporation operates in the medical technology industry and develops medical devices.